Actual Medicinal Product (AMP) Zidovudine 250mg capsules (A A H Pharmaceuticals Ltd)

This product can't be added to an MCA list.

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.

Provenance

This compatibility recommendation is derived from Retrovir 250mg capsules (ViiV Healthcare UK Ltd)

Generic
Zidovudine
Formulation
Zidovudine 250mg capsules
  • Zidovudine
    • Zidovudine 250mg capsules

      • Zidovudine 250mg capsules (A A H Pharmaceuticals Ltd)